Jan. 2, 2025 — Patients diagnosed with late-stage or metastatic breast cancer have a statistically significant increased risk of pre-diagnosis cardiovascular disease (CVD) compared to those with ...
Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) is pleased to announce amendments to its Manufacturing Services Agreement with CytoImmune Therapeutics ...
46.6 events; 95% CI, 0.42-0.82; p = 0.002). Finally, patients were symptomatically better in the device group, as measured with the Kansas City Cardiomyopathy Questionnaire-Overall Summary score, ...